Growth driven by increased injectable drug use, especially in outpatient settings
TB-500 loading phase (4 weeks) runs $120-180
GHK-Cu Research Areas: Skin & Hair Studies GHK-Cu research spans multiple independent laboratories worldwide, with primary focus areas including dermatological applications (wound healing acceleration, collagen synthesis stimulation, skin remodeling), hair follicle studies (follicle enlargement, growth cycle modulation), anti-inflammatory effects (reduction of TNF-alpha, IL-6 in macrophage models), and extracellular matrix remodeling (metalloproteinase regulation, glycosaminoglycan synthesis)
Disclosure of interest: Financial support for this study was provided by Alnylam Pharmaceuticals and Biogen Poster Session II - INTRACRANIAL HEMORRHAGE 02.00 - INTRACRANIAL HEMORRHAGE - 02.01 - INTRACEREBRAL HAEMORRHAGE P771 - ESOC25-495 PREHOSPITAL DETECTION OF INTRACRANIAL HEMORRHAGE USING A PORTABLE GFAP DEVICE IN PATIENTS WITH ACUTE FOCAL NEUROLOGICAL DEFICITS OR REDUCED CONSCIOUSNESS TRANSPORTED BY EMERGENCY VEHICLES Iris Voka 1 , Love-Preet Kalra 1 , Sabina Zylyftari 1 , Mastura Ganji 1 , Deepak Bos 1 , Klodiana Meci 1 , Stephan Barthelmes 1 , Gregor Lichy 2,3 , Simon Schwarzach 4 , Till Frscher 5 , Dominik Mayer 5 , Jens Pluto 5 , Timo Breining 5 , Sebastian Luger 1,6 , Christian Foerch 1,6 1 Department of Neurology, RKH Klinikum, Ludwigsburg, Germany, 2 Department of Anesthesiology, Intensive Care Medicine and Pain Medicine, RKH Klinikum, Ludwigsburg, Germany, 3 DRF Luftrettung Stuttgart, Stuttgart, Germany, 4 DRF Luftrettung Karlsruhe, Karlsruhe, Germany, 5 DRK Rettungsdienst Ludwigsburg, Ludwigsburg, Germany, 6 Department of Neurology, University Hospital Frankfurt, Goethe-University, Frankfurt am Main, Germany Background and Aims: Intracerebral hemorrhage(ICH) requires rapid diagnosis for optimal patient outcomes
